ArticleArchives of virology2025
Effect of trypsin digestion on the integrity and antigenic epitopes of GII.6 norovirus virus-like particles.
Article in Archives of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Trypsin digestion of the GII.6 norovirus (NoV) major capsid protein VP1 promotes its binding to histo-blood group antigens (HBGAs), which are believed to be co-receptors for NoVs. In our previous study, we found that trypsin digestion led to the disassembly of GII.6 NoV virus-like particles (VLPs). In this study, we investigated the effect of trypsin digestion on the integrity of GII.6 NoV VLPs using a modified purification approach and determined the N- and C-terminal residues of the fragments produced by digestion, using peptide mass fingerprinting. We also characterized the antigenic epitopes that were affected by trypsin digestion using monoclonal antibodies (mAbs). Our results indicated that GII.6 VLPs remained intact even after complete cleavage at the P1-1/P2 junction. Most of the mAbs in supernatants of hybridoma cell clones showed reduced binding to trypsin-digested GII.6 VLPs. Eight mAbs that showed reduced binding to digested GII.6 VP1 were produced, and these were found primarily to recognize residues located in the P domain. Our results provide evidence of flexibility and extensive morphological changes in the antigenic epitope of GII.6 VLPs after trypsin digestion. It remains to be investigated whether this phenomenon also occurs in virions.
Indexed as
Identifiers
39762616What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.